| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 27 |
| 1 | METHOTREXATE SODIUM | 20 |
| 2 | METHOTREXATE | 19 |
| 3 | TACROLIMUS | 11 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 5 | TACROLIMUS OINTMENT 0.1% | 11 |
| 6 | CYCLOPHOSPHAMIDE | 10 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 9 | CYTARABINE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | UNDECYLENIC ACID | 1 | 0.0072 |
| 1 | TOLNAFTATE 1% | 1 | 0.0034 |
| 2 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 4 | 0.0024 |
| 3 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 4 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 5 | BELATACEPT | 5 | 0.0011 |
| 6 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 7 | ANIDULAFUNGIN | 1 | 0.0006 |
| 8 | LETERMOVIR | 2 | 0.0006 |
| 9 | TROPICAMIDE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 51 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 5 | Benzodiazepine [EPC] | 11 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 7 | Alkylating Drug [EPC] | 10 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 9 | Azole Antifungal [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 5 | 0.0011 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0006 |
| 3 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 7 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 4 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |